|

AK112 with SCRT and CapeOX Clinical Trials

1 actively recruiting trial

Also known as: CapeOX, short-course radiotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • fan li1

Indications

  • Rectal Cancer1
  • Cancer1

Other1 trial

Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.